A Dose Of Innovation: Understanding The Perceptions And Potential Of Clinical Research

The PA Consulting Clinical Trials Pulse Report 2024 presents a compelling picture of public perceptions, challenges, and innovation opportunities in clinical trial design and delivery. Surveying 2,000 U.S. respondents, the study confirms broad recognition of clinical trials’ essential role in advancing life-saving medicines—77% consider them vital, and 64% are comfortable sharing personal health data to accelerate research.

Yet despite growing acceptance, participation barriers remain: fear of side effects, unclear information, lack of trust, and limited accessibility. The report identifies key strategies biopharma companies can adopt to address these issues and modernize the trial experience. Respondents also indicated strong interest in pragmatic and decentralized trials that reduce participant burden and in platforms that simplify enrollment and enhance communication. Meanwhile, trust in clinical trials remains higher for local hospitals and universities than for large pharmaceutical companies, signaling a need for better collaboration with credible institutions.

Ultimately, the report calls for a transformation of clinical trials into more inclusive, efficient, and digitally enabled systems. By aligning innovation with participant expectations, the industry can reduce costs, accelerate timelines, and ensure more equitable access to future therapies.